BackGreenLight Biosciences- Warrants (30/09/2027) Overview

GreenLight Biosciences- Warrants (30/09/2027) Other Current Liabilities

Latest other current liabilities for GRNAW: $12M.

Get informed when a big investor buys or sells

+ Follow
Other Current Liabilities
$12.20M
↑ 25.99% YoYΔ $2.52M vs prior year quarter

Peer trimmed avg / median

Loading

GreenLight Biosciences- Warrants (30/09/2027) Other Current Liabilities History

Loading

GreenLight Biosciences- Warrants (30/09/2027) vs. peers: Other Current Liabilities Comparison

Loading

GreenLight Biosciences- Warrants (30/09/2027) Other Current Liabilities Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Balance Sheet Breakdown

Current CashShort Term InvestmentsReceivablesInventoryOther Current AssetsCurrent AssetsLong Term InvestmentsProperty Plant EquipmentGoodwillIntangible AssetsOther AssetsTotal AssetsNet Tangible AssetsAccounts PayableOther Current LiabilitiesTotal Current LiabilitiesLong Term DebtOther LiabilitiesMinority InterestTotal Liabilities

GreenLight Biosciences- Warrants (30/09/2027) (GRNAW) FAQ

As of the most recent data (March 2023), GRNAW shows a other current liabilities of $12M. That compares with $9.7M in the prior-year period — up 26.0% year over year. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, GRNAW's other current liabilities is now $12M (was $9.7M) — a 26.0% year-over-year increase. Pairing that YoY change with peer averages gives a clearer picture of whether GreenLight Biosciences- Warrants (30/09/2027) is outperforming or lagging.

Tracking GRNAW's other current liabilities over time shows whether GreenLight Biosciences- Warrants (30/09/2027) is scaling, shrinking, or reshaping that part of the business. The current reading is $12M That compares with $9.7M in the prior-year period — up 26.0% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this other current liabilities page, Stockcircle has GreenLight Biosciences- Warrants (30/09/2027)'s full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect other current liabilities (currently $12M) with ownership activity and broader fundamentals.